Catheter Precision VTAK
NYSE VTAK
$0.17 -0.02 (-10.83%)
As of: Sep 9, 2026 · 3:59 PM EDT

Catheter Precision (VTAK) EBITDA Margin Growth (3y) (2020 - 2026)

Analysis

Catheter Precision (VTAK) EBITDA Margin Growth (3y) (2020 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin Growth (3y) (Qtr)
1 Abbott Laboratories 183.04 Bn 177.44 Bn 7.27 Bn -201.00
2 Intuitive Surgical 125.02 Bn 119.81 Bn 1.96 Bn 722.00
3 Medtronic 117.84 Bn 109.02 Bn 6.34 Bn 162.00
4 Stryker 105.50 Bn 102.02 Bn 4.50 Bn 586.00
5 Boston Scientific 66.27 Bn 65.73 Bn 3.85 Bn 736.00
6 Edwards Lifesciences 49.60 Bn 45.35 Bn 1.35 Bn 887.00
7 Alcon 33.70 Bn 32.24 Bn 1.68 Bn -1,075.00
8 Dexcom 32.06 Bn 30.11 Bn 830.00 Mn 963.00
9 Steris 21.02 Bn 20.54 Bn 684.20 Mn 244.00
10 Catheter Precision 480,427.59 -1.36 Mn 98,000.00 618,271.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 618,271.00
Mar 31, 2026 7.77 Mn
Jun 30, 2025 16.70 Mn
Mar 31, 2025 5.86 Mn
Dec 31, 2024 16.32 Mn
Sep 30, 2024 14.49 Mn
Jun 30, 2024 -220,091.00
Mar 31, 2024 16.86 Mn
Sep 30, 2023 898,707.00
Jun 30, 2023 -544,683.00
Mar 31, 2023 -7.76 Mn
Jun 30, 2022 -16.85 Mn
Mar 31, 2022 -6.03 Mn
Dec 31, 2021 -16.45 Mn
Sep 30, 2021 -14.76 Mn
Jun 30, 2021 -4,171.00
Mar 31, 2021 -17.15 Mn
Sep 30, 2020 -1.09 Mn